financetom
Business
financetom
/
Business
/
Nukkleus Stock Soars To Fresh Highs On Tiltan Defense Tech Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nukkleus Stock Soars To Fresh Highs On Tiltan Defense Tech Deal
Sep 2, 2025 8:51 AM

Nukkleus Inc. ( NUKK ) shares soared on Tuesday after the company said it will acquire Israel-based Tiltan Software Engineering Ltd. in a $14 million deal. The acquisition, to be paid in a mix of cash and stock, is expected to close following regulatory approval and audited financials.

The announcement underscores growing demand for AI-powered simulation and GPS-denied navigation tools that help militaries operate in contested environments and reduce civilian risk.

Tiltan, a three-decade-old defense technology firm, develops synthetic data for machine learning, GPS-denied navigation for drones and unmanned systems, and immersive 3D environments for operational testing. Its clients include Israel Aerospace Industries, Elbit Systems ( ESLT ) , and Rafael Advanced Defense Systems, with multiple awards from Israel's Defense Ministry recognizing its innovation.

Also Read: Nukkleus Stock Drops Over 7% After Hours: What’s Going On?

"This partnership marks a major milestone in Nukkleus' ( NUKK ) expansion into high-value aerospace and defense technologies," CEO Menny Shalom said in a statement. He cited Tiltan's AI-driven simulation platforms and battlefield navigation systems as key drivers for positioning Nukkleus ( NUKK ) in the global market.

Payment terms include installments and shares placed in escrow to secure final settlement. Sellers will receive shares equal to 25% of the purchase price on the 180th day after closing, adjusted for market value. The structure is designed to balance flexibility with protection against price swings.

Nukkleus ( NUKK ) held Cash and cash equivalents of $1.519 million as of June 30, 2025.

The deal remains subject to approval from Israel's Defense Export Controls Agency. It follows Nukkleus' ( NUKK ) recent strategic European aerospace venture, which also boosted investor sentiment.

Sector ETFs, including the iShares U.S. Aerospace & Defense ETF and SPDR S&P Aerospace & Defense ETF ( XAR ) , track the industry's rapid evolution.

Price Action: NUKK shares are trading 39.2% higher at $6.78 at the last check on Tuesday.

Read Next:

Genius Group Strikes $14 Million Deal To Build Bitcoin-Powered Education City In Bali

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved